Lysosomal modulation of antigen presentation

"Lysosomal modulation of antigen presentation" refers to the cellular processes by which **lysosomes regulate the degradation and processing of internalized antigens for loading onto major histocompatibility complex (MHC) molecules**. This is a critical step in both MHC class II–mediated presentation to CD4+ T cells and cross-presentation on MHC class I molecules to CD8+ T cells. The efficiency and specificity with which dendritic cells and other professional antigen-presenting cells control their **lysosomal proteolytic environment**—through regulation of pH, expression levels of cathepsins such as cathepsin S, NOX2-mediated alkalization, organelle positioning via GTPases like Rab34/Arl8b, and signaling through mTOR—determine how well they can generate peptide epitopes suitable for T cell recognition while avoiding complete degradation[1][2][3][4]. Pathogens can subvert these processes to evade immunity. However, "Lysosomal activity/modulation" itself is not a single protein/receptor/enzyme but rather describes an integrated set of cellular mechanisms involving multiple molecular players. Fine control over lysosomal degradation is essential for effective but limited processing required for adaptive immunity; this involves regulated expression/activity of proteases like cathepsins as well as dynamic changes in organelle morphology controlled by signaling pathways such as PI3K-Akt-mTOR[1][3][4]. Because this entry does not refer to a specific molecule but instead describes a broad functional process involving many components at the cellular/organelle level—and because it cannot be mapped cleanly onto standard drug-target categories—it should be flagged as incorrect if used where only discrete therapeutic targets are appropriate.

Other names

Lysosomal activity in antigen presentationLysosome-mediated antigen processingLysosome function in immune response